Araştırma Makalesi
Yıl 2019,
Cilt: 41 Sayı: 2, 348 - 356, 30.06.2019
Öz
Kaynakça
- 1. M. Coutinho, H.C. Gerstein, Y. Wang, S. Yusuf. The relationship between glucose and incident cardiovascular events: A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years Diabetes Care, 22 (1999), pp. 233-2402. E.B. Levitan, Y. Song, E.S. Ford, S. LiuIs nondiabetic hyperglycemia a risk factor for cardiovascular disease?: A meta-analysis of prospective studies Arch Intern Med, 164 (2004), pp. 2147-21553. G. Danaei, C.M. Lawes, H.S. Vander, C.J. Murray, M. Ezzati Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment Lancet, 368 (2006), pp. 1651-16594. International Diabetes Federation (2017) Diabetes Atlas, 8th edn. Available from http://www.diabetesatlas.org/. Accessed 20 May 20185. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997; 14 (Suppl. 5): S1–85.6. Michael M, Engelgau KM, Venkat N, William HH. Screening for Type 2 Diabetes. Diabetes Care 2000; 23(10):1563-80.7. Belgi, A., Diabetic Cardiomyopathy and Heart Failure, Turkish Cardiology Seminars, October 2007, Number 5, s4748. Nichols GA, Hillier TA, Brown JB. Progression From Newly Acquired Impaired Fasting Glucose to Type 2 Diabetes. Diabetes Care 2007; 30: 228–233. 9. The DECODE Study Group. Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes Diabetologia 2003; 46: 608–617.10. The DECODE Study Group Consequences of the new diagnostic criteria for diabetes in older men and women. DECODE Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe). Diabetes Care 1999; 22: 1667– 1671.11. Chiasson JL et al. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 2003; 290: 486–494.12. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ et al (1995). A new index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function—a study in normals and dilated cardiomyopathy. J Cardiol 26: 357–36813. Tei C, Dujardin KS, Hodge DO, Kyle RA, Tajik AJ, Seward JB (1996) Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. Am Coll Cardiol 28: 658–66414. Bruch C, Schmermund A, Marin D, Katz M, Bartel T, Schaar J, Erbel R (2000) Tei-index in patients with mild-to-moderate congestive heart failure. Eur Heart J 21(22):888–89515. Tavil Y, Ozturk MA, Sen N, Kaya MG, Hizal F, Poyraz F, Turfan M, Onder M, Gurer MA, Cengel A. The assessment of cardiac functions by tissue Doppler-derived myocardial performance index in patients with Behcet's disease. Clin Rheumatol. 2008 Mar; 27(3):309-314. Epub 2007 Aug 3.16. Mishra RK, Kizer JR, Palmieri V, Roman MJ, Galloway JM., Fabsitz RR, Lee ET, Utility Of The Myocardial Performance Index İn A Population With High Prevalences Of Obesity, Diabetes, And Hypertension: The Strong Heart Study Echocardıography: A Jrnl. Of Cv Ultrasound & Allied Tech. Vol. 24, No. 4, 200717. Shetty P, Kumanyika S, Ko GT. Waist circumference and waist-hip ratio: report of a World Health Organization expert consultation, Geneva, 8-11 December 2008.18. Schiller NB, Shah PM, Crawford M, et al. Recommmadation of quantitation of the left ventricle by two dimensional echocardiography. American Society of Echocardiography Committee on standards, Subcommittee on Two-Dimensional Echocardiogram. J Am Soc Echocardiogr 1989; 2:358-367.19. Wild S, Roglic G, Gren A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and Project for 2030. Diabetes Care 2004; 27(5):1047-5320. Rodrigues B, Cam MC, McNeill JH. Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biol Biochem. 1998;180,53–5721. Airaksinen KEJ, Salmela PI, Linnaluoto MK, Ikaheimo MJ, Ahola K, Ryhanen LJ: Diminished arterial elasticity in diabetes: association with şu o recent advanced glycosylation end products in collagen. Cardiovasc Res 27.942–945, 199322. Depre C, Young ME, Ying J, et al. Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. J Mol Cell Cardiol. 2000; 32.985–996.23. Heinecke JW. Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis. Am J Cardiol 2003;91(Suppl):12–6A.24. Ceriello A. Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects. Diabetologia 1993;36: 1119–25.25. Ceriello A, Falleti E, Motz E, et al. Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress. Horm Metab Res 1998; 30: 146–9.26. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813–20.27. Rudski LG, Lai WW, Afilalo J, et al.Guidelines fort he echocardiographic assessment of the right heart in adults:a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography ,a registered branch of the European Society of Cardiology,and the Canadian of Echocardiography,J Am Soc Echocardigr.2010;23(7):685-713. 28. Özer N. Kalp yetmezliğinin semptom ve bulguları. Editörler Kozan Ö. Zoghi M. A‟ dan Z‟ ye Kalp Yetersizliği. Güneş Tıp Kitabevi 2010; 7:89-94. 29. M. Fujita et al. / International Journal of Cardiology 118 (2007) 76–8030. Di Bonito P, Cuomo S, Moio N, et al. Diastolic dysfunction in patients with non-insulin-dependent diabetes mellitus of short duration. Diabet Med 1996; 13: 321–4.31. Kaftan A. H. Kalp Yetersizliği Etiyolojisi. Editörler Kozan Ö. Zoghi M. A‟ dan Z‟ ye Kalp Yetersizliği. Güneş Tıp Kitabevi 2010; 5: 49-5632. Mizushige K, Yao L, Noma T, et al. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin resistant prediabetic stage of a type II diabetic rat model. Circulation 2000; 101: 899– 907.33. Goldstein RH, Poliks CF, Pilch PF, Smith BD, Fine A. Stimulation of collagen formation by insulin and insulin-like growth factor I in cultures of human lung fibroblasts. Endocrinology 1989; 124: 964– 70.34. Sterdlow AJ, Jones ME. Mortality during 25 years of follow-up of a cohort with diabetes, Int J Epidemiol 1999;25(6):1250-61.35. Hu FB, Stampfer MJ, Haffner SM, et al, Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes, Diabetes care 2002;25(7):1129-34.36. Kihara N, Sasson S, Feener EP, et al.Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells.Diabetes 1993;42(1):80-90.37. Brownlee M, Friedman E, Vinik Al, Nesto RW, Boultın AJM. Complications of Diabetes Mellitus. Ed: K. Larsen, Kronenberg, Melmed, Polonsky, Williams Textbook of Endocrinology.pp.1510-1583, Saunders, Philadelphia, USA, 200338. I Stratton, A. Alder, H. Neil, D. Natthews, S Manley, C. Cull and on behalf of the UKPDS Study Group, UKPDS 35: Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): a prospective observational study. BMJ 2000: 321; 405-12.
Yıl 2019,
Cilt: 41 Sayı: 2, 348 - 356, 30.06.2019
Öz
Objective:
Prediabetes; is the first stage of
diabetes. It is a high-risk status for the development of diabetes mellitus
type 2, which is an important public health problem. Myocardial performance
index (MPI) is a noninvasive method that can be measured by echocardiography
showing left ventricular (LV) systolic and diastolic functions. In this study,
we aimed to investigate the relationship between prediabetes and MPI.
Method: Fifty-three consecutive patients without
chronic illness who were diagnosed with prediabetes and 48 otherwise healthy
subjects were enrolled in the study. Fasting blood glucose and HbA1c levels were measured from venous
blood samples. MPI values were
calculated by tissue Doppler imaging technique for all participants.
Results: In the prediabetic group,
the mean fasting blood glucose level was 115 ± 4 mg/dL, whereas in the control
group it was 90 ± 5 mg/dL.
As expected, HbA1c was statistically significantly higher in the patient group.
(% 5,7 ± 0,3 vs % 5,1±0,3, respectively). The MPI
values in the patient group were higher than the control group and this
difference was statistically significant (0.74 ± 0.12 vs. 0.64 ± 0.09;
p<0,001). There
were no statistically significant differences between the groups in terms of
age, gender, and body mass index.
Conclusions: In
prediabetic patients, MPI was higher than the control group, which may be
related to impaired LV systolic and diastolic functions.
Anahtar Kelimeler
Prediabetes Myocardial Performance Index Tissue Doppler Imaging
Kaynakça
- 1. M. Coutinho, H.C. Gerstein, Y. Wang, S. Yusuf. The relationship between glucose and incident cardiovascular events: A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years Diabetes Care, 22 (1999), pp. 233-2402. E.B. Levitan, Y. Song, E.S. Ford, S. LiuIs nondiabetic hyperglycemia a risk factor for cardiovascular disease?: A meta-analysis of prospective studies Arch Intern Med, 164 (2004), pp. 2147-21553. G. Danaei, C.M. Lawes, H.S. Vander, C.J. Murray, M. Ezzati Global and regional mortality from ischaemic heart disease and stroke attributable to higher-than-optimum blood glucose concentration: comparative risk assessment Lancet, 368 (2006), pp. 1651-16594. International Diabetes Federation (2017) Diabetes Atlas, 8th edn. Available from http://www.diabetesatlas.org/. Accessed 20 May 20185. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med 1997; 14 (Suppl. 5): S1–85.6. Michael M, Engelgau KM, Venkat N, William HH. Screening for Type 2 Diabetes. Diabetes Care 2000; 23(10):1563-80.7. Belgi, A., Diabetic Cardiomyopathy and Heart Failure, Turkish Cardiology Seminars, October 2007, Number 5, s4748. Nichols GA, Hillier TA, Brown JB. Progression From Newly Acquired Impaired Fasting Glucose to Type 2 Diabetes. Diabetes Care 2007; 30: 228–233. 9. The DECODE Study Group. Gender difference in all-cause and cardiovascular mortality related to hyperglycaemia and newly-diagnosed diabetes Diabetologia 2003; 46: 608–617.10. The DECODE Study Group Consequences of the new diagnostic criteria for diabetes in older men and women. DECODE Study (Diabetes Epidemiology: Collaborative Analysis of Diagnostic Criteria in Europe). Diabetes Care 1999; 22: 1667– 1671.11. Chiasson JL et al. Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 2003; 290: 486–494.12. Tei C, Ling LH, Hodge DO, Bailey KR, Oh JK, Rodeheffer RJ et al (1995). A new index of combined systolic and diastolic myocardial performance: a simple and reproducible measure of cardiac function—a study in normals and dilated cardiomyopathy. J Cardiol 26: 357–36813. Tei C, Dujardin KS, Hodge DO, Kyle RA, Tajik AJ, Seward JB (1996) Doppler index combining systolic and diastolic myocardial performance: clinical value in cardiac amyloidosis. Am Coll Cardiol 28: 658–66414. Bruch C, Schmermund A, Marin D, Katz M, Bartel T, Schaar J, Erbel R (2000) Tei-index in patients with mild-to-moderate congestive heart failure. Eur Heart J 21(22):888–89515. Tavil Y, Ozturk MA, Sen N, Kaya MG, Hizal F, Poyraz F, Turfan M, Onder M, Gurer MA, Cengel A. The assessment of cardiac functions by tissue Doppler-derived myocardial performance index in patients with Behcet's disease. Clin Rheumatol. 2008 Mar; 27(3):309-314. Epub 2007 Aug 3.16. Mishra RK, Kizer JR, Palmieri V, Roman MJ, Galloway JM., Fabsitz RR, Lee ET, Utility Of The Myocardial Performance Index İn A Population With High Prevalences Of Obesity, Diabetes, And Hypertension: The Strong Heart Study Echocardıography: A Jrnl. Of Cv Ultrasound & Allied Tech. Vol. 24, No. 4, 200717. Shetty P, Kumanyika S, Ko GT. Waist circumference and waist-hip ratio: report of a World Health Organization expert consultation, Geneva, 8-11 December 2008.18. Schiller NB, Shah PM, Crawford M, et al. Recommmadation of quantitation of the left ventricle by two dimensional echocardiography. American Society of Echocardiography Committee on standards, Subcommittee on Two-Dimensional Echocardiogram. J Am Soc Echocardiogr 1989; 2:358-367.19. Wild S, Roglic G, Gren A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and Project for 2030. Diabetes Care 2004; 27(5):1047-5320. Rodrigues B, Cam MC, McNeill JH. Metabolic disturbances in diabetic cardiomyopathy. Mol Cell Biol Biochem. 1998;180,53–5721. Airaksinen KEJ, Salmela PI, Linnaluoto MK, Ikaheimo MJ, Ahola K, Ryhanen LJ: Diminished arterial elasticity in diabetes: association with şu o recent advanced glycosylation end products in collagen. Cardiovasc Res 27.942–945, 199322. Depre C, Young ME, Ying J, et al. Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. J Mol Cell Cardiol. 2000; 32.985–996.23. Heinecke JW. Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis. Am J Cardiol 2003;91(Suppl):12–6A.24. Ceriello A. Coagulation activation in diabetes mellitus: the role of hyperglycaemia and therapeutic prospects. Diabetologia 1993;36: 1119–25.25. Ceriello A, Falleti E, Motz E, et al. Hyperglycemia-induced circulating ICAM-1 increase in diabetes mellitus: the possible role of oxidative stress. Horm Metab Res 1998; 30: 146–9.26. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001; 414: 813–20.27. Rudski LG, Lai WW, Afilalo J, et al.Guidelines fort he echocardiographic assessment of the right heart in adults:a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography ,a registered branch of the European Society of Cardiology,and the Canadian of Echocardiography,J Am Soc Echocardigr.2010;23(7):685-713. 28. Özer N. Kalp yetmezliğinin semptom ve bulguları. Editörler Kozan Ö. Zoghi M. A‟ dan Z‟ ye Kalp Yetersizliği. Güneş Tıp Kitabevi 2010; 7:89-94. 29. M. Fujita et al. / International Journal of Cardiology 118 (2007) 76–8030. Di Bonito P, Cuomo S, Moio N, et al. Diastolic dysfunction in patients with non-insulin-dependent diabetes mellitus of short duration. Diabet Med 1996; 13: 321–4.31. Kaftan A. H. Kalp Yetersizliği Etiyolojisi. Editörler Kozan Ö. Zoghi M. A‟ dan Z‟ ye Kalp Yetersizliği. Güneş Tıp Kitabevi 2010; 5: 49-5632. Mizushige K, Yao L, Noma T, et al. Alteration in left ventricular diastolic filling and accumulation of myocardial collagen at insulin resistant prediabetic stage of a type II diabetic rat model. Circulation 2000; 101: 899– 907.33. Goldstein RH, Poliks CF, Pilch PF, Smith BD, Fine A. Stimulation of collagen formation by insulin and insulin-like growth factor I in cultures of human lung fibroblasts. Endocrinology 1989; 124: 964– 70.34. Sterdlow AJ, Jones ME. Mortality during 25 years of follow-up of a cohort with diabetes, Int J Epidemiol 1999;25(6):1250-61.35. Hu FB, Stampfer MJ, Haffner SM, et al, Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes, Diabetes care 2002;25(7):1129-34.36. Kihara N, Sasson S, Feener EP, et al.Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cells.Diabetes 1993;42(1):80-90.37. Brownlee M, Friedman E, Vinik Al, Nesto RW, Boultın AJM. Complications of Diabetes Mellitus. Ed: K. Larsen, Kronenberg, Melmed, Polonsky, Williams Textbook of Endocrinology.pp.1510-1583, Saunders, Philadelphia, USA, 200338. I Stratton, A. Alder, H. Neil, D. Natthews, S Manley, C. Cull and on behalf of the UKPDS Study Group, UKPDS 35: Association of glycemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): a prospective observational study. BMJ 2000: 321; 405-12.
Toplam 1 adet kaynakça vardır.
Ayrıntılar
| Birincil Dil | İngilizce |
|---|---|
| Konular | Sağlık Kurumları Yönetimi |
| Bölüm | Medical Science Research Makaleler |
| Yazarlar | |
| Yayımlanma Tarihi | 30 Haziran 2019 |
| Kabul Tarihi | 27 Haziran 2019 |
| Yayımlandığı Sayı | Yıl 2019Cilt: 41 Sayı: 2 |